INTRODUCTION
============

Macroautophagy (hereafter referred to as autophagy) is a bulk degradative pathway in which double-membraned structures called autophagosomes enclose damaged proteins and organelles. Fusion of autophagosomes with the endolysosomal system delivers hydrolytic enzymes required to degrade the sequestered cytosolic components ([@B54]; [@B8]). Formation of the autophagosome is initiated by the activation of autophagy-related (Atg) proteins in a hierarchical manner. The molecular machinery of autophagy is highly conserved and primarily regulated by the mammalian target of rapamycin (mTOR), in response to the nutrient and metabolic status of the cell. Autophagy occurs at a basal level in most cells and is increased under conditions of stress, when it promotes survival by repurposing degraded material to support metabolism within the cell ([@B9]).

Inefficient autophagy has been implicated in the pathogenesis of neurodegenerative diseases, because postmitotic neurons are especially susceptible to the accumulation of defective organelles and protein aggregates ([@B42]). Autophagy is also critical for maintaining the health of the neural retina: in aged mice or mice with retina-specific deletions of *Atg5*, decreased autophagic flux precedes photoreceptor degeneration ([@B53]), and autophagy induction preserves differentiation of the retinal pigment epithelium (RPE) and prevents photoreceptor death after oxidative stress ([@B65]) or exposure to Fas ligand ([@B4]). In the postmitotic RPE, which nourishes and supports the overlying photoreceptors, autophagy is increased in response to diverse stressors, including exposure to intense light, oxidative stress, mitochondrial poisons, cigarette smoke, and cell swelling ([@B50]; [@B34], [@B35]; [@B7]; [@B11]; [@B61]).

A key function performed by the RPE critical for photoreceptor health is the circadian phagocytosis and lysosomal degradation of shed photoreceptor outer segment (OS) tips ([@B5]). Each RPE cell contacts 30--50 photoreceptors, which shed ∼10% of their OS length daily. Over a lifetime, this immense metabolic activity results in the progressive accumulation of undigested OS components called lipofuscin in RPE lysosomes ([@B57]). RPE lipofuscin differs from that in other postmitotic tissues in that it is primarily composed of bisretinoid metabolites of vitamin A, generated as by-products of the visual cycle ([@B12]). Light induces isomerization of the visual chromophore 11-*cis*-retinal (11CR) to all-*trans*-retinal (ATR), which is flipped by the ATP binding cassette transporter A4 (ABCA4) from the lumen to the cytosolic side of the disk membrane and reduced to nontoxic all-*trans*-retinol by retinol dehydrogenase 8 ([@B62]). Delayed removal of 11CR and ATR from disk membranes makes them susceptible to condensation reactions that ultimately result in the formation of vitamin A derivatives such as the lipofuscin bisretinoid A2E in RPE lysosomes ([@B57]). Once formed, lipofuscin bisretinoids remain in the RPE for life, because their unique structures render them resistant to lysosomal degradation.

Chronic accumulation of these bisretinoids has been implicated in the pathology of numerous blinding retinal diseases, including Stargardt disease, Best disease, and age-related macular degeneration (AMD; [@B2]; [@B57]). We previously demonstrated that A2E, a cone-shaped lipid, displaces cholesterol from lipid bilayers and sequesters cholesterol in RPE late endosomes and lysosomes ([@B36]). Because membrane cholesterol levels modulate autophagosome--lysosome interactions ([@B14]; [@B31]; [@B55]), we hypothesized that cholesterol storage induced by lipofuscin bisretinoids would inhibit autophagic clearance in the RPE. OS phagocytosis has been shown to recruit autophagic machinery in the RPE ([@B27]; [@B16]; [@B64]), and inefficient autophagy is thought to play a part in the pathogenesis of retinal diseases such as AMD ([@B6]; [@B16]). However, how innate processes such as progressive accumulation of lipofuscin bisretinoids impact autophagy in the RPE is not well understood.

In this paper, we report decreased autophagosome biogenesis and autophagic flux in the RPE of *ABCA4^−/−^* disease mice, which have high levels of A2E and other bisretinoids ([@B48]). High-speed live imaging of primary RPE by spinning-disk confocal microscopy ([@B58]) showed that A2E interfered with autophagosome biogenesis, constrained autophagosome traffic, and decreased autophagic flux. Our data unveil a stepwise molecular mechanism by which lipofuscin- and A2E-induced lysosomal cholesterol storage ([@B36]) activates acid sphingomyelinase (ASMase) by sequestering the anionic lipid bis(monoacylglycero)phosphate (BMP), an ASMase cofactor ([@B28]). The resulting increase in ceramide levels lead to increased tubulin acetylation ([@B23], [@B24]). Our data show that bidirectional motility of autophagosomes and autophagosome--lysosome fusion are impaired in cells with acetylated microtubules. In support of a central role for cholesterol-mediated ASMase activation in regulating autophagy, we demonstrate that a drug that promotes cholesterol efflux ([@B36]) and a U.S. Food and Drug Administration (FDA)-approved ASMase inhibitor ([@B32]) restore efficient autophagosome transport and autophagic flux in the RPE.

There are two significant implications of our study: first, our data show that autophagy in the RPE is regulated in response to the immense metabolic demands placed on the cell, adding to a growing body of evidence for specialized regulation of autophagy based on tissue, function, and context ([@B20]; [@B25]; [@B37]; [@B43]). Second, our studies suggest that ASMase inhibition could be a potential novel therapeutic strategy not only in macular degeneration associated with excess lipofuscin accumulation but also in diseases characterized by abnormal cholesterol homeostasis and impaired autophagy ([@B37]; [@B42]; [@B3]; [@B39]).

RESULTS
=======

Lipofuscin bisretinoids interfere with canonical autophagy in the RPE
---------------------------------------------------------------------

To investigate whether lipofuscin bisretinoids impact autophagy in vivo, we measured microtubule-associated light chain 3B-II (LC3B-II) and p62/SQSTM1 levels in RPE of *ABCA4^−/−^* mice, which have high levels of lipofuscin bisretinoids such as A2E ([@B48]). Conversion of LC3B-I to its lipidated form (LC3B-II) is an indicator of autophagosome biogenesis, and p62 levels are a measure of autophagic flux ([@B29]). *ABCA4^−/−^* RPE had significantly less LC3B-II ([Figure 1A](#F1){ref-type="fig"}) and more p62 ([Figure 1B](#F1){ref-type="fig"}) compared with RPE from age-matched wild-type mice, supporting the hypothesis that accumulation of lipofuscin bisretinoids is associated with defective autophagy in vivo. To determine how lipofuscin bisretinoids inhibit autophagy in the RPE, we established an in vitro model by exposing polarized porcine primary RPE monolayers ([@B58]) to the bisretinoid A2E, chronically (50 nM over 3 wk) or acutely (10 μM for 6 h), either of which result in intracellular A2E levels comparable with those seen in the RPE of *ABCA4^−/−^* mice and in human Stargardt disease patients (Supplemental Table S1).

![Regulation of autophagy in the RPE. (A) Representative immunoblot and quantification of LC3B-II levels in the RPE of 3- and 6-mo-old wild-type (gray bars) and *ABCA4^−/−^* (black bars) mice. Significantly less than age-matched wild-types, *n* ≥ 9 animals per group; \*, *p* \< 0.05. (B) Immunohistochemistry for p62 (green) in retinal cryosections from 6-mo-old wild-type and *ABCA4^−/−^* mice. PR, photoreceptors; RPE, retinal pigment epithelium. Scale bar: 20 μm. (C) Stills from live imaging of tfLC3 in primary RPE to monitor basal autophagy and autophagic flux after mTOR inhibition by serum starvation or Torin1 and Torin 2 (both for 2 h). (D) Quantification of EGFP/mRFP ratios of cells in C. \*, significantly greater than corresponding control cells, *p* \< 0.01, *n* = 30 cells per condition. (E) Representative immunoblot of LC3B-I, LC3B-II, and p62 protein levels in control or A2E-laden primary RPE monolayers untreated or treated with torins ± bafilomycin A1 (Baf, 100 nM for 2 h). (F) Quantification of LC3B-II immunoblots, *n* ≥ 9 per condition; \*, *p* \< 0.01; n.s., not significant. (G) Quantification of p62 immunoblots, *n* ≥ 9 per condition; \*\*, *p* \< 0.001; n.s., not significant.](1fig1){#F1}

In polarized primary RPE cells, autophagy was up-regulated after mTOR inhibition, either by nutrient deprivation or treatment with the selective mTOR inhibitors Torin 1 and Torin 2. We used tandem fluorescent monomeric red fluorescent protein (mRFP) enhanced green fluorescent protein (EGFP) LC3 (tfLC3) to monitor autophagy in primary RPE cells in real time. On fusion of autophagosomes with lysosomes, EGFP fluorescence is quenched in the acidic lysosomal pH, and only the pH-insensitive mRFP signal is visible; therefore ratios of EGFP to mRFP are a measure of autophagic flux ([@B29]). TfLC3 imaging showed significantly more EGFP puncta in cells treated with A2E compared with control cells, both at the basal level and after mTOR inhibition either by nutrient deprivation or Torin treatment ([Figure 1, C](#F1){ref-type="fig"} and [D](#F1){ref-type="fig"}).

Immunoblotting of polarized primary RPE monolayers after mTOR inhibition showed significantly lower LC3B-II levels in cells treated with A2E compared with control RPE. The vacuolar ATPase inhibitor bafilomycin A1, which prevents lysosomal degradation of LC3B, increased LC3B-II after mTOR inhibition in control cells but not in cells exposed to A2E ([Figure 1, E](#F1){ref-type="fig"} and [F](#F1){ref-type="fig"}). To confirm that A2E decreased autophagosome biogenesis, we immunostained primary RPE monolayers for WD repeat domain, phosphoinositide interacting 2 (WIPI2)-positive preautophagosomal structures ([@B47]). There were fewer WIPI2-labeled nascent autophagosomes at the basal state and after mTOR inhibition in cells with A2E, compared with control cells (Supplemental Figure S1). Immunoblotting also showed that there was significantly more p62 in cells with A2E after Torin treatment ([Figure 1, E](#F1){ref-type="fig"} and [G](#F1){ref-type="fig"}), indicating a block in autophagic flux. Taken together, these data suggest that lipofuscin bisretinoids interfere with canonical autophagy in vivo in the *ABCA4^−/−^* mice and in primary RPE cells in culture.

Autophagosome trafficking is disrupted in RPE with the bisretinoid A2E
----------------------------------------------------------------------

Because tfLC3 imaging and p62 immunoblotting data showed a block in autophagosome--lysosome fusion and decreased autophagic flux in RPE with bisretinoids, we asked whether A2E interfered with the trafficking of autophagosomes. We performed live imaging of EGFP-LC3--labeled autophagosomes in untreated or A2E-laden primary RPE cells using high-speed spinning-disk confocal microscopy. After serum starvation to induce autophagy, RPE with A2E had fewer EGFP-LC3 motile tracks compared with control cells ([Figure 2, A](#F2){ref-type="fig"} and [C](#F2){ref-type="fig"}, and Supplemental Movies S1 and S2). We used four-dimensional image analysis (Imaris, Bitplane) to quantify changes in autophagosome trajectories induced by A2E. To examine the efficiency of autophagosome transport, we used Spots and Tracks algorithms in Imaris to calculate how far each autophagosome traveled (track displacement length) as a function of the movement required to travel that distance (total track length) ([@B40]). Analysis of track displacement data by Boolean gating showed a significant decrease in the population of autophagosomes with long-range, directed movements (large displacement with long track lengths) in cells with A2E ([Figure 2, B](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}, and [Table 1](#T1){ref-type="table"}). Compared with control cells, RPE with A2E had fewer motile autophagosomes (aggregate number of motile tracks was 17,010 in control cells and 5914 in cells with A2E), which moved with significantly lower velocities ([Figure 2E](#F2){ref-type="fig"}). How could A2E, which is present in RPE late endosomes and lysosomes ([@B36]), interfere with autophagosome trafficking?

![Live imaging of autophagosome trafficking in the RPE. (A and C) Stills from live imaging of EGFP-LC3 with spots and tracks superimposed in serum-starved RPE (A) untreated (control) or (C) exposed to A2E. Right, high-magnification images of areas denoted by white boxes on the left. (B and D) Plots of track displacement of EGFP-LC3--labeled autophagosomes vs. total track length in untreated cells (B) or cells exposed to A2E (D). Boolean gating was used to analyze data as explained in *Material and Methods*. See [Table 1](#T1){ref-type="table"} for R1, R2, and R3 percentages. (E) Frequency histogram of EGFP-LC3--labeled autophagosome velocities (μm/sec) from Supplemental Movies S1 and S2. Gray bars, control cells; black bars, cells treated with A2E.](1fig2){#F2}

###### 

Quantitation of EGFP-LC3 trafficking data (from [Figures 2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"}).

                Region 1 (R1) (*D* \< 2 μm, *L* \< 5 μm)   Region 2 (R2) (*L* \> 5 μm, slope \< 0.5 μm)   Region 3 (R3) (*L* \> 5 μm, slope \> 0.5 μm)
  ------------- ------------------------------------------ ---------------------------------------------- ----------------------------------------------
  Control (%)   87.57                                      6.56                                           5.87
  A2E (%)\*     93.51                                      5.37                                           1.12
  TSA (%)\*     88.01                                      10.35                                          1.64

\*Significantly different from control cells, *p* \< 0.0001, one-way ANOVA.

Excess cholesterol mediates autophagic defects in RPE with bisretinoids
-----------------------------------------------------------------------

A critical determinant of organelle motility and fusion is membrane cholesterol ([@B38]; [@B14]). We showed previously that A2E, a cone-shaped lipid, competes with cholesterol (another cone-shaped lipid) for space under the phospholipid umbrella to minimize unfavorable interactions with the aqueous phase. Displacement of cholesterol from the lipid bilayer traps cholesterol within RPE late endosomes and lysosomes ([@B36]). A2E and other lipofuscin bisretinoids increased total cell cholesterol measured biochemically in primary RPE after chronic or acute exposure ([Figure 3A](#F3){ref-type="fig"}) and in the RPE of 3- and 6-mo-old *ABCA4^−/−^* mice ([Figure 3B](#F3){ref-type="fig"}). We then asked whether A2E-induced cholesterol accumulation was responsible for autophagic defects. To test this, we treated cells with the liver X receptor alpha (LXRα) agonist TO901317, which transcriptionally activates ABCA1 and ABCG1 cholesterol transporters, to clear excess cholesterol in cells with A2E ([@B36]; Supplemental Figure S2A). Immunoblotting and quantification of LC3B-II and p62 protein levels after mTOR inhibition showed that TO901317 increased autophagosome biogenesis ([Figure 3, C](#F3){ref-type="fig"} and [D](#F3){ref-type="fig"}) and autophagic flux in A2E-laden cells ([Figure 3, C](#F3){ref-type="fig"} and [E](#F3){ref-type="fig"}). We used live imaging of tfLC3 to follow autophagosome--lysosome fusion: TO901317 restored autophagic flux in cells with A2E and decreased EGFP fluorescence back to control levels ([Figure 3, F](#F3){ref-type="fig"} and [G](#F3){ref-type="fig"}). Collectively these data confirm that excess cholesterol induces defects in autophagosome trafficking and autophagosome--lysosome fusion in cells with lipofuscin bisretinoids.

![Cholesterol removal restores autophagosome biogenesis and autophagic flux in RPE with lipofuscin bisretinoids. (A) Biochemical quantification of cholesterol in polarized primary RPE, untreated (control) or exposed to A2E as indicated. Mean ± SEM, \*, *p* \< 0.005 relative to controls. (B) Total RPE cholesterol in eyecups from wild-type and *ABCA4^−/--^* mice. Mean ± SEM, *n* ≥ 9 per group. \*\*, *p* \< 0.005 relative to age-matched wild-types. (C) Representative immunoblot of LC3B-I, LC3B-II, and p62 protein levels in control or A2E-laden primary RPE monolayers. Cells were untreated or treated with torins, bafilomycin (Baf, 100 nM for 2 h), and/or the LXRα agonist TO901317 (1 μM, 20 h), as indicated. (D) Quantification of LC3B-II immunoblots, *n* ≥ 9 per condition; \*, *p* \< 0.05; \*\*, *p* \< 0.01; n.s., not significant; \#, significantly greater than corresponding condition without TO901317 (in red hatched bars), *p* \< 0.05. (E) Quantification of p62 immunoblots, *n* ≥ 9 per condition; \*, *p* \< 0.05; n.s., not significant; \#, significantly less than corresponding condition without TO901317 (in red hatched bars), *p* \< 0.05. (F) Stills from live imaging of mRFP-GFP-LC3 in serum-starved RPE treated as indicated. (G) Quantification of EGFP (green) to mRFP (red) fluorescence in F. Mean ± SEM, \*, significantly greater than all other treatments, *p* \< 0.05.](1fig3){#F3}

Tubulin acetylation on stable microtubules impairs autophagosome trafficking
----------------------------------------------------------------------------

Intracellular trafficking is coordinated by the actin and micro­tubule cytoskeletons and associated motor proteins ([@B52]). Organelle-specific recruitment of microtubule motors is accomplished in part by posttranslational modifications of α-tubulin such as acetylation and detyrosination, which preferentially occur on stable microtubules and cause cell type--specific alterations of organelle motility ([@B26]; [@B44]). To examine how bisretinoid-induced cholesterol accumulation interferes with autophagy in the RPE, we asked whether altered microtubule stability and/or posttranslational tubulin modifications could explain the constrained trafficking of autophagosomes. Immunostaining showed that acetylated tubulin, which is mainly found in primary cilia of control RPE, increased dramatically in cells with A2E, with a corresponding decrease in tyrosinated tubulin ([Figure 4, A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}). Neither total β-tubulin expression (Supplemental Figure S2B) nor the organization of the actin cytoskeleton (Supplemental Figure S2C) were altered in these cells. RPE from 6-mo-old *ABCA4^−/−^* mice had more acetylated tubulin compared with age-matched wild-types ([Figure 4C](#F4){ref-type="fig"}), confirming that bisretinoids increase tubulin acetylation in vivo. Under conditions that depolymerize microtubules in polarized epithelia (nocodazole and cold treatment; [@B33]), there were significantly more acetylated microtubules in A2E-laden cells compared with controls ([Figure 4, D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}), indicative of increased microtubule stability. Acetylated tubulin also increased in cells treated with U18666A, a drug that induces lysosomal cholesterol storage ([@B30]; Supplemental Figure S2D), suggesting that cholesterol mediates the effects of A2E on microtubule stability and tubulin acetylation. To establish that hyperacetylation of tubulin disrupts autophagosome traffic, we performed live imaging of EGFP-LC3 trafficking in RPE treated with trichostatin A (TSA), an inhibitor of histone deacetylase 6 (HDAC6), the enzyme that deacetylates tubulin ([@B26]). Confirming our hypothesis, TSA treatment replicated the autophagosome trafficking defects seen in cells with A2E ([Figure 4, F](#F4){ref-type="fig"} and [G](#F4){ref-type="fig"}, Supplemental Movie S3, and [Table 1](#T1){ref-type="table"}). Thus bisretinoid-induced cholesterol storage prevents autophagosome trafficking by increasing tubulin acetylation.

![Tubulin acetylation modulates autophagosome trafficking in the RPE. (A) Immunofluorescence images of polarized primary RPE, untreated or exposed to A2E and stained for acetylated tubulin (green) and ZO-1 (red) or tyrosinated tubulin (green) and phalloidin to label actin (red). (B) Relative intensities of acetylated and tyrosinated tubulin staining in RPE. Mean ± SEM, \*, *p* \< 0.0001 relative to corresponding controls. (C) Immunohistochemistry for acetylated tubulin (red) in retinal cryosections from 6-mo-old wild-type and *ABCA4^−/−^* mice. PR, photoreceptors; RPE, retinal pigment epithelium. Scale bar: 20 μm. (D) Cells stained for acetylated tubulin (green) and ZO-1 (red) after nocodazole (33 μM) and cold treatment for 30 min. (E) Number of acetylated microtubules longer than 5 μm after nocodazole and cold treatment. Mean ± SEM, \*, *p* \< 0.0001. (F) Still from live imaging of EGFP-LC3 trafficking with spots and tracks superimposed in primary RPE treated with the HDAC6 inhibitor TSA (500 nM). (G) Track displacement of EGFP-LC3--labeled autophagosomes vs. total track length in TSA-treated cells in F analyzed by Boolean gating (see [Table 1](#T1){ref-type="table"} for values).](1fig4){#F4}

ASMase activation promotes hyperacetylation of tubulin in the RPE
-----------------------------------------------------------------

To dissect the molecular mechanism that links bisretinoid-stimulated cholesterol accumulation in the endolysosomal system with tubulin acetylation, we sought clues from cholesterol-storage disorders like Niemann-Pick C1 (NPC1). In NPC1 fibroblasts, excess cholesterol in late endosomes and lysosomes sequesters the anionic phospholipid BMP ([@B46]). BMP is a cofactor for ASMase, the lysosomal enzyme that hydrolyzes sphingomyelin to generate ceramide ([@B28]). Recent studies show that ceramide regulates tubulin acetylation via atypical protein kinase C (aPKC) and aurora A kinase ([@B23], [@B24]). In polarized primary RPE with A2E, immunofluorescence imaging showed high levels of BMP, which colocalized with filipin staining for cholesterol ([Figure 5A](#F5){ref-type="fig"}). Cells with A2E also had high ASMase activity ([Figure 5B](#F5){ref-type="fig"}) and more ceramide ([Figure 5C](#F5){ref-type="fig"}) compared with control RPE. Treatment with desipramine, a functional inhibitor of ASMase ([@B32]), decreased ASMase activity and ceramide levels ([Figure 5, B](#F5){ref-type="fig"} and [C](#F5){ref-type="fig"}). Desipramine also decreased acetylated tubulin in cells with A2E ([Figure 5D](#F5){ref-type="fig"}), confirming that cholesterol increases tubulin acetylation via a BMP-ASMase-ceramide pathway.

![BMP-mediated activation of ASMase promotes tubulin acetylation. (A) Immunofluorescence images of polarized primary RPE, untreated (Control) or exposed to A2E, as indicated, labeled with filipin (blue) and stained for BMP (red) and ZO-1 (purple). (B) ASMase activity in primary RPE untreated (control) or treated with A2E and/or the ASMase inhibitor desipramine (Des, 10 μM for 3 h). \*, *p* \< 0.005 relative to all other conditions (one-way ANOVA, Dunnett\'s posttest). (C) Immunofluorescence staining for ceramide (red) and ZO-1 (white) in untreated cells (control) or cells treated with A2E and/or desipramine. (D) Immunofluorescence staining for acetylated tubulin (green) and ZO-1 (red) in untreated cells (control) or cells treated with A2E and/or desipramine.](1fig5){#F5}

Inhibition of ASMase activity corrects autophagic defects in the RPE
--------------------------------------------------------------------

If, as the above data indicate, ASMase is a critical regulator of autophagy, then ASMase inhibition should be sufficient to restore autophagic flux in RPE with bisretinoid-mediated cholesterol accumulation. We first performed live imaging of EFGP-LC3, and image analyses of trafficking data ([Figure 6A](#F6){ref-type="fig"} and Supplemental Movies S4 and S5) showed that desipramine increased both the number of motile tracks and long-range displacement of autophagosomes in RPE cells with A2E ([Figure 6, B--E](#F6){ref-type="fig"}, and [Table 2](#T2){ref-type="table"}). After mTOR inhibition, a short exposure to desipramine increased LC3B-II levels in RPE with A2E comparable with those in control cells ([Figure 7, A](#F7){ref-type="fig"} and [B](#F7){ref-type="fig"}). Desipramine also decreased p62 levels in cells with A2E ([Figure 7, A](#F7){ref-type="fig"} and [C](#F7){ref-type="fig"}), indicating a restoration of autophagic flux. In agreement with immunoblotting data, tfLC3 imaging showed that desipramine corrected defects in autophagosome--lysosome fusion after serum starvation ([Figure 7D](#F7){ref-type="fig"}) and Torin treatment ([Figure 7E](#F7){ref-type="fig"}) in RPE cells with A2E. Thus ASMase inhibition could be an effective therapeutic target to increase cellular clearance in RPE with lipofuscin bisretinoids.

![Desipramine corrects autophagosome trafficking defects in the RPE. (A) Stills from live imaging of EGFP-LC3 with spots and tracks superimposed in serum-starved RPE treated as indicated. Des, desipramine. (B--E) Analyses of live-imaging data depicted as track displacement of EGFP-LC3--labeled autophagosomes vs. total track length in control cells and cells treated with A2E and/or desipramine. Boolean gating was used to analyze data as explained in *Materials and Methods*. See [Table 2](#T2){ref-type="table"} for R1, R2, and R3 percentages.](1fig6){#F6}

![Inhibition of ASMase activity restores autophagic flux in RPE with the lipofuscin bisretinoid A2E. (A) Representative immunoblot of LC3B-I, LC3B-II, and p62 protein levels in control or A2E-laden primary RPE monolayers. Cells were untreated or treated with torins, bafilomycin (Baf, 100 nM for 2 h), and desipramine (Des, 10 μM, 3 h) as indicated. (B) Quantification of LC3B-II immunoblots, *n* ≥ 9 per condition; \*\*, *p* 0.01; n.s., not significant; \#, significantly greater than corresponding condition without desipramine (in red hatched bars), *p* \< 0.01. (C) Quantification of p62 immunoblots, *n* ≥ 9 per condition; \*\*, *p* \< 0.01; n.s., not significant; \#, significantly lesser than corresponding condition without desipramine (in red hatched bars), *p* \< 0.001. (D) Stills from live imaging of mRFP-GFP-LC3 and quantification of EGFP/mRFP ratios in serum-starved RPE treated as indicated. \*\*, significantly greater than all other treatments, *p* \< 0.0001. (E) Stills from live imaging of tfLC3 and quantification of EGFP/mRFP ratios in torin-treated RPE treated as indicated. \*, significantly greater than all other treatments, *p* \< 0.01.](1fig7){#F7}

###### 

Quantitation of EGFP-LC3 trafficking data (from [Figure 6, B--E](#F6){ref-type="fig"}).

                Region 1 (R1) (*D* \< 2.5 μm, *L* \< 10 μm)   Region 2 (R2) (*L* \> 10 μm, slope \< 0.5 μm)   Region 3 (R3) (*L* \> 10 μm, slope \> 0.5 μm)
  ------------- --------------------------------------------- ----------------------------------------------- -----------------------------------------------
  Control (%)   85.73                                         7.57                                            6.7
  Des (%)       84.28                                         7.79                                            7.93
  A2E (%)\*     91.43                                         5.28                                            3.29
  A2E+des (%)   83.88                                         7.77                                            8.35

\*Significantly different from all other conditions, *p* \< 0.0001, one-way ANOVA.

DISCUSSION
==========

We describe here a novel molecular mechanism by which autophagy is derailed by lipofuscin bisretinoids and excess cholesterol ([Figure 8](#F8){ref-type="fig"}), which progressively accumulate in the RPE and contribute to the pathogenesis of macular degeneration ([@B1]; [@B6]; [@B45]). Although decreased autophagy within the retina is thought to participate in the pathogenesis of retinal dystrophies ([@B6]; [@B16]), little is currently known about the precise mechanisms involved or how autophagy can be exploited as a potential drug target to maintain RPE health.

![Model for impaired autophagy in RPE with bisretinoids. (A) Cone-shaped bisretinoids like A2E (1) sequester cholesterol (2) in RPE late endosomes and lysosomes, as we have reported previously ([@B36]). Data presented in this study show that excess cholesterol in turn traps BMP (3), which activates ASMase (4), leading to increased production of ceramide from sphingomyelin (5). Ceramide promotes tubulin acetylation on stable microtubules (6), possibly by inhibiting HDAC6. Acetylated microtubules in the RPE interfere with autophagosome motility (7). (B) In normal RPE, autophagosome biogenesis and transport are essential for efficient autophagic flux. (C) Our data show that, in RPE with bisretinoids, aberrant activation of ASMase interferes with multiple steps of autophagy by increasing ceramide-induced tubulin acetylation. Whether acetylated microtubules also interfere with the trafficking of other organelles like phagosomes, endosomes, and lysosomes is currently under investigation. Drugs that inhibit ASMase decrease tubulin acetylation and increase autophagy in cells with lipofuscin bisretinoids (8).](1fig8){#F8}

The data presented in this study identify ASMase as a critical regulator of autophagy in RPE compromised by lipofuscin-mediated cholesterol accumulation. We show that in cells with bisretinoids, cholesterol sequesters the anionic lipid BMP within RPE late endosomes and lysosomes. BMP activates ASMase, the enzyme that hydrolyzes sphingomyelin to ceramide, which in turn promotes tubulin acetylation on stable microtubules. Studies in polarized epithelia and neural progenitors show that ceramide inhibits the microtubule deacetylase HDAC6 by preventing the translocation of aPKC from the membrane to the cytosol. This interferes with aPKC-mediated phosphorylation of two HDAC6 activators, aurora A kinase and glycogen synthase kinase 3β, resulting in the accumulation of acetylated tubulin ([@B23], [@B24]). Ceramide can also phosphorylate the focal adhesion scaffold protein paxillin ([@B56]), which has been recently identified as a negative regulator of HDAC6 activity ([@B10]). Whether any of these mechanisms are responsible for ceramide-induced tubulin acetylation in RPE with bisretinoids remains to be determined.

Live-imaging data showed impaired autophagosome biogenesis and trafficking as a consequence of increased tubulin acetylation, either due to lipofuscin bisretinoids or after treatment with the HDAC6 inhibitor TSA. Acetylation is a posttranslational modification of α-tubulin that can act either singly or in concert with other modifications such as tyrosination/detyrosination to control motor recruitment in cargo-specific manner ([@B21]; [@B41]). Precisely how posttranslational modifications of tubulin modulate the trafficking of autophagosomes and other organelles is not well understood. Acetylated microtubules in neurons preferentially recruit kinesin-1 and the scaffolding protein JNK-interacting protein 1 (JIP1) to direct polarized traffic to a subset of neurites ([@B49]). Binding of JIP1 to the kinesin heavy-chain motor domain of kinesin-1 accelerates anterograde traffic, whereas JIP1 binding to the p150^Glued^ subunit of the dynein--dynactin complex promotes retrograde traffic. JIP1 has recently been shown to bind LC3 in neurons to direct dynein-mediated retrograde transport of autophagosomes. Interestingly, the LC3-JIP1 interaction interferes with JIP1-mediated activation of kinesin-1 ([@B18]). Unlike autophagosomes in neurons, which undergo unidirectional retrograde transport along the axon ([@B18]), autophagosomes in the RPE, as shown by our data, exhibit bidirectional motility, likely driven by opposing actions of kinesin and dynein motors ([@B17]). It is possible that acetylated microtubules in RPE with bisretinoids preferentially recruit kinesin-1 ([@B49]), which would then compete with LC3 for JIP1 binding ([@B18]). We also observed fewer tyrosinated microtubules in cells with A2E, which could interfere with the recruitment of p150^Glued^/dynactin ([@B51]). Thus, in RPE with bisretinoids, increased acetylation and decreased tyrosination of tubulin could interfere with bidirectional autophagosome transport, possibly by altering the recruitment of motor proteins and/or preventing interactions between motors, scaffolds, and cargo. Further studies will help dissect the roles of these motor and scaffolding proteins in directing the transport of autophagosomes and other organelles (endosomes, lysosomes, phagosomes, etc.) in the RPE.

How might increased tubulin acetylation interfere with autophagosome biogenesis? At the earliest stages of autophagosome formation, phosphatidylinositol 3-phosphate binds its effectors WIPI1 and WIPI2 to catalyze the sequential recruitment of Atg proteins that regulate elongation of the preautophagosomal membrane. The fully formed Atg5-Atg12-Atg16L complex induces covalent conjugation of phosphatidylethanolamine to LC3 and facilitates autophagosome closure. Movement of these preautophagosomes along dynamic microtubules is necessary for both Atg recruitment and for driving subsequent steps of autophagosome formation ([@B19]). It is therefore likely that increased stability of acetylated microtubules in cells with A2E interferes with the recruitment of Atg proteins, which decreases membrane elongation and autophagosome biogenesis.

Our data demonstrate that desipramine, a tricyclic antidepressant that increases ASMase proteolysis ([@B32]), restores autophagy in RPE with A2E by reversing ceramide-induced tubulin acetylation. Thus functional ASMase inhibitors, many of which are FDA-approved drugs with established safety and efficacy profiles ([@B32]), are promising candidates for inherited macular dystrophies characterized by elevated levels of lipofuscin bisretinoids such as Stargardt and Best diseases ([@B59]). Lipofuscin bisretinoids are also implicated in AMD, the most common cause of vision loss in older adults ([@B1]). In this context, it is intriguing to note that allelic variants in cholesterol transporters and lipoprotein-metabolizing enzymes modulate susceptibility to AMD ([@B15]) and that use of tricyclic antidepressants like desipramine is associated with a statistically significant decrease in the risk of developing early AMD ([@B60]). Furthermore, ASMase activity and ceramide levels are increased in the brains of patients with Alzheimer\'s and Parkinson\'s diseases ([@B22]; [@B13]), which are associated with dysregulated autophagy ([@B42]). It is tempting to speculate that ASMase inhibition could be a novel therapeutic approach not only for retinal degeneration but also for neurodegenerative diseases.

MATERIALS AND METHODS
=====================

Cells
-----

Primary RPE were harvested from freshly enucleated porcine eyes (Hart and Vold, Baraboo, WI) as previously described ([@B58]): briefly, the anterior segment was removed at the ora serrata, and the retina was gently detached by clipping at the optic nerve head. RPE cells were isolated from eyecups upon incubation with 0.5% trypsin with 5.3 mM EDTA in Hank\'s balanced salt solution and plated onto T25 flasks in DMEM with 1% heat-inactivated fetal bovine serum (FBS; American Type Culture Collection, Manassas, VA). For generation of polarized cultures, cells were plated at confluence (∼300,000 cells/cm^2^) onto collagen-coated Transwell (Corning, Corning, NY) semipermeable membrane filters. After 2 wk, monolayers had transepithelial electrical resistances of \>300 ohm.cm^2^, localized Na^+^, K^+^-ATPase apically, and expressed tight junction proteins (e.g., ZO-1) and RPE differentiation markers (e.g., RPE65) ([@B58]).

Animals
-------

Wild-type and *ABCA4^−/−^* mice (both 129/Sv strain on Rpe65 Leu-450 background) were raised under a 12-h cyclical light and fed a standard rodent diet (NIH-31, 7013; Harlan Teklad, Madison, WI). Mouse studies were done in adherence to guidelines established by the University of California--Los Angeles Animal Research Committee and the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research. Animals were killed ∼4--6 h after light onset and eyes were removed and hemisected. The anterior portion containing the cornea, lens, and vitreous was discarded. Eyecups containing retina, RPE, choroid, and sclera were frozen in liquid N~2~ and stored at −80°C for further processing ([@B48]).

Immunoblotting
--------------

RPE harvested from mouse eyecups were sonicated in lysis buffer with protease inhibitors for 10 min. Primary RPE on Transwell filters were harvested and lysed with NE-PER nuclear and cytoplasmic extraction reagents (\#78833; Thermo Scientific, Rockford, IL) according to the manufacturer\'s recommendation. Protein concentrations were measured with DC assay (Bio-Rad, Hercules, CA). Samples (20 μg/lane) were resolved in 4--12% NuPAGE Bis-Tris Precast Gels (Invitrogen, Carlsbad, CA) at 130 V. Proteins were then transferred onto nitrocellulose membrane using the iBlot dry transfer system (Invitrogen) and blocked in 5% milk in Tris buffered saline with Tween20 (TBS-T) for 1 h before being incubated in primary antibody overnight at 4°C. Membranes were probed with antibodies to LC3B (1:3000; Novus \[St. Louis, MO\] NB600-1384 for pig and 1:500; Sigma-Aldrich \[St. Louis, MO\] L7543 for mouse), p62/SQSTM1 (1:1000; American Research Products \[Waltham, MA\] ARP03-GP62-C) and actin (1:5000; Santa Cruz Biotechnology, Dallas, TX) followed by horseradish peroxidase--conjugated secondary antibodies. Immunoblots were visualized by ECL substrate (Thermo Scientific) and quantified using Image Studio (LI-COR, Lincoln, NE).

Pharmacological treatments
--------------------------

The lipofuscin bisretinoid A2E was synthesized according to published protocols and purified by high-performance liquid chromatography (HPLC; \>97%, electrospray ionization mass spectrometry; [@B36]). RPE were exposed to either a chronic low-dose of A2E (50 nM for 3 wk) or an acute high-dose of A2E (10 μM for 6 h, followed by a 48-h chase). Quantification of A2E levels in cells was performed by HPLC as previously reported ([@B48]). Other drugs used were the mTOR inhibitors Torin 1 and Torin 2 (50 nM and 1.5 μM, respectively, for 2 h; Tocris Bioscience, Bristol, UK), the vacuolar ATPase inhibitor bafilomycin A1 (100 nM for 2 h; EMD Millipore, Billerica, MA), the LXRα agonist TO901317 (1 μM for 20 h; Cayman Chemicals, Ann Arbor, MI), the HDAC6 inhibitor TSA (500 nM, 16 h; Sigma-Aldrich), and the ASMase inhibitor desipramine (10 μM for 3 h; Sigma-Aldrich). For depolymerization of MTs, cells were treated with 33 μM nocodazole for 30 min; this was followed by cold treatment (4°C) for 30 min ([@B33]). At the concentrations and exposure times used, none of these drugs caused alterations in RPE cell morphology or physiology (monitored by TER measurements and ZO-1 and organelle marker staining).

Immunofluorescence staining and quantification
----------------------------------------------

Filter-grown cells were fixed in 2% paraformaldehyde for 10 min, blocked in 1% bovine serum albumin (BSA) in phosphate-buffered saline (PBS), and incubated with specific primary antibodies for 1 h: mouse monoclonal anti--acetylated tubulin clone 6-11B-1 (1:1000; Sigma-Aldrich), rat monoclonal anti-tyrosinated α-tubulin (1:200; Santa Cruz), mouse anti-LBPA (1:500; Echelon Biosciences, Salt Lake, UT; Z-LBPA), mouse anti-ceramide (1:10; Enzo Life Sciences, Farmingdale, NY) and rat anti--Z0-1 (1:3000; [@B63]). Alexa Fluor secondary antibodies were used at 1:500 and rhodamine--phalloidin (Cytoskeleton, Denver, CO; PHDR1) at 1:200. Filters were mounted under coverslips on glass slides under Vectashield (Vector Labs, Peterborough, UK), sealed and visualized with an Andor (Belfast, UK) Revolution XD spinning-disk confocal microscope using a 60×/1.4 NA oil objective with identical exposures and gains for each antibody. Acetylated tubulin-labeled stable microtubules (≥5 μm in length) after nocodazole treatment were analyzed manually in the Surpass mode of Imaris (Bitplane, South Windsor, CT).

Immunohistochemistry
--------------------

Cryosections of wild-type and *ABCA4^−/−^* mouse retinas were blocked in PBS with 4% BSA and incubated with primary antibodies (diluted 1:100 in PBS with 4% BSA) for 48 h at 4°C in a humidified chamber. Slides were rinsed to remove unbound antibodies and incubated with Alexa Fluor--conjugated secondary antibodies (1:500 in PBS with 4% BSA) for 18 h at 4°C in a humidified chamber protected from light. Sections were rinsed, stained with 4′,6-diamidino-2-phenylindole for 5 min, and rinsed and sealed under coverslips using Vectashield as a mounting medium. Slides were imaged with the Andor Revolution XD spinning-disk confocal microscope using a 40×/1.4 NA oil objective with identical exposures and gains for each antibody.

Transfections
-------------

RPE cells were transfected with EGFP-LC3 (Addgene, Cambridge, MA; plasmid \# 21073) or tfLC3 (Addgene; plasmid \#21075) using the Amaxa nucleofector II (Lonza, Rockland, ME). Approximately 1.5 million cells and 5 μg plasmid DNA were used for each transfection. Cells were plated on either serum-coated glass-bottom dishes (MatTek, Ashland, MA) or Transwell filters at confluence.

Spinning-disk microscopy
------------------------

Live imaging of autophagosome traffic and autophagic flux was performed on the Revolution XD spinning-disk microscopy system (Andor) equipped with the Yokogawa CSU-X1 confocal spinning-disk head; Nikon Eclipse Ti inverted microscope surrounded by an Okolab cage incubator; iXon x3 897 EM-CCD camera; Andor laser combiner with four solid-state lasers at 405, 488, 561, and 640 nm and corresponding band-pass filter sets (Sutter, Novato, CA); and ASI motorized stage with piezo-Z for rapid Z-stack acquisition. Andor IQ2 software was used for image acquisition and Imaris ×64 (Bitplane) for image analysis. For live imaging, cells were serum starved for 2 h to induce autophagy and rapid Z-stacks were acquired using the 100×/1.49 NA Apo TIRF objective (Nikon, Melville, NY) for ∼50 frames at 37°C. Trafficking data were collected from three separate transfections for a total of at least 12--30 movies captured for treatment. During image acquisition, care was taken to maintain the same laser power, exposure and electron-multiplying gain settings. Trafficking analysis was carried out using the Spots and Tracks modules of the Imaris software ([@B40]). After background subtraction (using the background-subtraction algorithm and identical automatic threshold for all images) and smoothing (Gaussian algorithm with identical threshold settings for all images), Spots and Tracks algorithms were used to identify vesicles and follow them through time and cell space to obtain total track length and track displacement. Statistical analysis of these data sets was performed using Excel (Microsoft, Redmond, WA) and Prism (GraphPad, La Jolla, CA).

Biochemical assays
------------------

Cells were harvested by trypsinization, and cell pellets were washed with PBS to remove residual medium. Cells were lysed in HNTG lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 10% glycerol, 1.5 mM MgCl~2~, 1% Triton X-100) supplemented with protease inhibitors. Total protein was measured using the DC protein assay kit (Bio-Rad). Cellular cholesterol was quantified using the Amplex Red cholesterol assay kit (Invitrogen) as detailed previously ([@B36]). Single eyecups from wild-type and *ABCA4^−/−^* mice were homogenized in 50 μl of lysis buffer and processed as above. For measuring ASMase activity, cells were lysed in acidic pH, and assays were performed using the sphingomyelinase fluorometric assay kit from Cayman Chemicals according to the manufacturer\'s protocol.

Statistical analysis
--------------------

Data were analyzed using either a two-tailed *t* test or one-way analysis of variance (ANOVA) followed by Bonferroni or Dunnett\'s posttests (GraphPad Prism). Unless otherwise stated, data are presented as mean ± SEM of three or more independent experiments, with three to four replicates per condition per experiment. To analyze EGFP-LC3 trafficking data, we used Boolean gating to segment three regions (denoted by R1, R2, and R3 on the track displacement vs. total track length graphs). Regions were defined by: minimum or maximum track length, minimum or maximum displacement, and a slope of 0.5 (displacement divided by length). Tracks with a slope \<0.5 were taken as less straight (R2) than those with a slope of \>0.5 (R3). Tracks within each region are represented as a percent of total number of tracks in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. One-way ANOVA or *t* tests were used to compare regions between treatment groups.
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